Black Rock Inc. Dyne Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,390,042 shares of DYN stock, worth $172 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,390,042

Previous 3,788,682 42.27%

Holding current value

$172 Million

Previous $50.4 Million 203.68%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.06 - $29.18 $20.9 Million - $46.7 Million	1,601,360 Added 42.27%	5,390,042 $153 Million
Q4 2023 Feb 13, 2024	BUY	$6.62 - $13.64 $3.19 Million - $6.57 Million	481,717 Added 14.57%	3,788,682 $50.4 Million
Q3 2023 Nov 13, 2023	SELL	$8.6 - $12.18 $130,909 - $185,403	-15,222 Reduced 0.46%	3,306,965 $29.6 Million
Q2 2023 Aug 11, 2023	BUY	$8.53 - $14.28 $6 Million - $10 Million	702,966 Added 26.84%	3,322,187 $37.4 Million
Q1 2023 May 12, 2023	BUY	$10.88 - $15.0 $6,560 - $9,045	603 Added 0.02%	2,619,221 $30.2 Million

Q4 2022 Feb 13, 2023	BUY	$9.37 - $13.8 $876,572 - $1.29 Million	93,551 Added 3.7%	2,618,618 $30.3 Million
Q3 2022 Nov 14, 2022	BUY	$7.2 - $15.17 $364,096 - $767,131	50,569 Added 2.04%	2,525,067 $32.1 Million
Q2 2022 Aug 12, 2022	BUY	$4.36 - $10.5 $477,494 - $1.15 Million	109,517 Added 4.63%	2,474,498 $17 Million
Q1 2022 May 12, 2022	SELL	$6.52 - $12.27 $302,632 - $569,524	-46,416 Reduced 1.92%	2,364,981 $22.8 Million
Q4 2021 Feb 10, 2022	BUY	$11.89 - $16.07 $5.03 Million - $6.8 Million	423,245 Added 21.29%	2,411,397 $28.7 Million
Q3 2021 Nov 09, 2021	BUY	$15.6 - $21.46 $248,726 - $342,158	15,944 Added 0.81%	1,988,152 $32.3 Million
Q2 2021 Aug 11, 2021	BUY	$15.94 - $22.33 $31.4 Million - $44 Million	1,972,208 New	1,972,208 $41.5 Million

Others Institutions Holding DYN

# of Institutions

176

Shares Held

87.1M

Call Options Held

130K

Put Options Held

209K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.65B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account